LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas to participate on panel, "Investing in Neurotech" at Neurotech Investing and Partnering Conference in Boston, MA
News | 05. 19. 2010
